Símbolo | YTM % | Volumen | Precio % | Cupón % | Fecha de vencimiento | Imp. pendiente | Valor nominal | Imp. mín. denom. | Emisor |
---|---|---|---|---|---|---|---|---|---|
RPHC5222528Royalty Pharma plc 3.35% 02-SEP-2051 | 7,40% | 600 K | 63,69% | 3,35% | 2051-09-02 | 700 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5237919Royalty Pharma plc 3.55% 02-SEP-2050 | 7,25% | 100 K | 66,84% | 3,55% | 2050-09-02 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5237891Royalty Pharma plc 3.3% 02-SEP-2040 | 6,98% | 1,6 M | 72,50% | 3,30% | 2040-09-02 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5824522Royalty Pharma plc 5.9% 02-SEP-2054 | 6,42% | 5,38 M | 94,67% | 5,90% | 2054-09-02 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5222527Royalty Pharma plc 2.15% 02-SEP-2031 | 5,91% | 20 K | 82,11% | 2,15% | 2031-09-02 | 600 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5824521Royalty Pharma plc 5.4% 02-SEP-2034 | 5,84% | 10,79 M | 97,29% | 5,40% | 2034-09-02 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5237916Royalty Pharma plc 2.2% 02-SEP-2030 | 5,68% | 4 K | 85,17% | 2,20% | 2030-09-02 | 996,81 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5824520Royalty Pharma plc 5.15% 02-SEP-2029 | 5,23% | 114 K | 99,70% | 5,15% | 2029-09-02 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5237354Royalty Pharma plc 1.75% 02-SEP-2027 | 5,06% | 250 K | 92,35% | 1,75% | 2027-09-02 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5237914Royalty Pharma plc 1.2% 02-SEP-2025 | 4,92% | 5,31 M | 97,75% | 1,20% | 2025-09-02 | 999,96 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5035520Royalty Pharma plc 2.2% 02-SEP-2030 | 2,37% | 0 | 98,72% | 2,20% | 2030-09-02 | 3,19 M USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |
RPHC5035516Royalty Pharma plc 1.2% 02-SEP-2025 | 1,30% | 0 | 99,62% | 1,20% | 2025-09-02 | 38 K USD | 1.000,00 USD | 2.000,00 USD | Royalty Pharma Plc |